Table 1 Baseline characteristics of the 106 patients
25-OHD (ng/ml) | 13.1 ± 0.6 |
|---|---|
Demographic characteristics | Â |
Recipient age (years) | 40.2 ± 1.1 |
Recipient gender (% women) | 31 (29.2) |
Active vitamin D supplementation before KT | 17 (16.0) |
Etiology of renal failure (%) | Â |
Diabetes mellitus | 10 (9.4) |
Glomerulonephritis | 32 (30.2) |
Hypertension and others | 64 (60.4) |
Duration of dialysis (months) | 16.8 ± 2.7 |
History of cardiovascular disease | 8 (7.5) |
Smoking | 22 (20.8) |
Body mass index (kg/m2) | 22.8 ± 0.3 |
Predominant RRT modality before KT (%) | Â |
Hemodialysis | 49 (46.2) |
Peritoneal dialysis | 22 (20.8) |
Pre-emptive transplantation | 35 (33.0) |
Transplant type | Â |
Living-related donor | 76 (71.7) |
Living-unrelated donor | 29 (27.4) |
Deceased donor | 1 (0.9) |
Donor characteristic | Â |
Donor age | 35.1 ± 1.0 |
Donor gender (% women) | 46 (43.4) |
ABO mismatch (%) | 15 (14.2) |
Number of HLA mismatches | 2.8 ± 0.1 |
Mismatch at A locus (%) | 83 (78.3) |
Mismatch at B locus (%) | 90 (84.9) |
Mismatch at DR locus (%) | 87 (82.1) |
Laboratory test results | Â |
Albumin (g/dl) | 3.8 ± 0.0 |
Calcium (mg/dl) | 9.1 ± 0.1 |
Albumin-corrected calcium (mg/dl) | 9.3 ± 0.1 |
Phosphorus (mg/dl) | 5.8 ± 0.2 |
Alkaline phosphatase (IU/l) | 68.6 ± 2.6 |
Parathyroid hormone (intact; pg/ml) | 204.6 ± 19.9 |
Osteocalcin (ng/ml) | 45.2 ± 4.0 |
Hemoglobin (g/l) | 9.5 ± 0.2 |
Biopsy-proven acute rejection episode | 11 (10.4) |